openPR Logo
Press release

Depressive Disorder Industry: Global Market Size, Trends, Outlook and 2020 Forecasts Research Report

04-21-2017 12:25 PM CET | Health & Medicine

Press release from: MarketReportsOnline

Depressive Disorder Industry: Global Market Size, Trends,

Depression is a serious mood disorder, affecting the ability to think, feel, and handle situations like sleeping, eating, or working. It is a mood disorder that causes a persistent feeling of sadness and loss of interest. It builds up a very negative perspective in the way of thinking in every single thing and damages a person’s ability to see brighter versions of any situation in life. It is of various types like major depressive disorder (MDD), perinatal depression, psychotic depression, seasonal depression and bipolar depression.

Complete report on Depressive disorder industry spread across 57 pages with providing 4 company profiles, 8 tables and 46 charts is now available at http://www.marketreportsonline.com/496438.html.

To be diagnosed with depression, the symptoms must be present for at least two weeks. It may require long-term treatment for years. There is no single cause of depression; it is likely an outcome from combinations of genetic, biochemical, environmental and physiological factors. There are several ways of treating depression depending upon each individual’s characteristics & symptoms. Most people feel better with medication, psychological counseling or both.

The global depressive disorder market is expected to grow and overcome falling revenues due to patent expiry with better innovative drugs and therapies. The US has highest depression disorder prevalence along with highest prevalence of bipolar depression & schizophrenia. With growing awareness and better access to medical facilities, the depressive disorder market is expected to grow worldwide, especially in Asia-Pacific region.

The key factors driving the growth of the depressive disorder market includes increased smoking prevalence, rising healthcare expenditure, growing female population, increasing spending on medicines and rising number of prescription drugs. However, there are certain factors hindering the growth of the market like patent expiry, severe side effects of drugs, and tough regulations. Major trends of the market include novel drug approvals, major drugs in pipeline, and growing public awareness.

Order a copy of this “Global Depressive Disorder Market” research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=496438.

The report offers an in-depth analysis of the “Global Depressive Disorder Market” segmented into global and regional markets. Competition is concentrated in the hands of few major pharmaceutical companies out of which Pfizer Inc., AstraZeneca, Eli Lilly and company, and Lundbeck have been covered in the report.

Few Points from List of Charts:
Types of Depression
Causes & Symptoms of Depression
Global Depressive Disorder Market by Value (2010-2015)
Global Depressive Disorder Market Forecast by Value (2016-2020)
Global Depressive Disorder Market by Region (2015)
Global Anti-Depressant Drug Market by Value (2010-2015)
Global Anti-Depressant Drug Market Forecast by Value (2016-2020)
Global Anti-Psychotic Drug Market by Value (2010-2015)
Global Anti-Psychotic Drug Market Forecast by Value (2016-2020)
The US Depressive Disorder Market Forecast by Value (2015-2020)
The US Mental Health Drug Prescription by Volume (2011-2015)
The US Depressive Disorder Patient Prevalence Forecast (2016-2020)
The US Bipolar Depression Patient Prevalence Forecast (2016-2020)

Browse All Latest Reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Depressive Disorder Industry: Global Market Size, Trends, Outlook and 2020 Forecasts Research Report here

News-ID: 510393 • Views:

More Releases from MarketReportsOnline

US Lettuce & Chicory Market Key Players, Exports & Imports, Size, Share, Demands …
The US lettuce and chicory market is forecasted to reach US$5.09 billion in 2026, experiencing growth at a CAGR of 2.62% during the period spanning from 2022 to 2026. Growth in the lettuce and chicory market is supported by factors such as rising population, rising middle class spending, shift towards veganism/ vegetarianism, increasing awareness regarding the health benefit of chicory and rising social media influence. However, the market growth is
Global Breast Biopsy Market - Hologic, Danaher Corporation, Becton, Dickinson & …
The global breast biopsy market is forecasted to reach US$1.75 billion in 2025, experiencing growth at a CAGR of 8.56% for the period spanning 2022-202. Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However,
Global Contract Development & Manufacturing Organization Market - Catalent, Inc. …
The global Contract Development & Manufacturing Organization (CDMO) market is estimated to reach US$246.6 billion in 2026, growing at a CAGR of 9.31%, for the period spanning 2022-2026. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market.
Korean Gaming Market (Mobile, PC and Console) - Netmarble, Pearl Abyss, NCSoft, …
The Korean gaming market is anticipated to reach US$20.98 billion in 2026, growing at a CAGR of 6.21% during the period spanning 2022-2026. After the U.S., China, and Japan, it is the fourth largest market, accounting for more than 6% of the worldwide gaming industry in 2021. The growth in the market has been driven by factors like rising smartphone penetration, rapid urbanization, rising gaming subscribers' penetration rate, expansion of MMORPGs,

All 5 Releases


More Releases for Depressive

Anxiety & Depressive Disorder Treatment Market Projected to Show Strong Growth
Global Anxiety & Depressive Disorder Treatment Market Report from DiMarket highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player's market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions
Major Depressive Disorder Market: Global Industry Analysis and Forecast (2024-20 …
Major Depressive Disorder Market Overviews Major Depressive Disorder (MDD) is a community mental illness characterized by a persistently low mood that conflicts with the person's ability to work, sleep, eat, and other activities. MDD is also indicated as clinical depression or recurrent depression. The symptoms of this mental disorder are loss of interest, recurrent thoughts of death, insomnia, feelings of worthlessness, and decreased ability to think. To access more details regarding this
Major Depressive Disorder Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Major Depressive Disorder Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Major Depressive Disorder pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Major Depressive Disorder Pipeline Insights Report 2023 (Updated)
DelveInsight's, "Major Depressive Disorder Pipeline Insight 2023" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Major Depressive Disorder
Major Depressive Disorder (MDD) - Drug Pipeline Landscape, 2022
Major Depressive Disorder (MDD) also known as clinical depression, is a severe mood disorder which causes persistent or extended periods of depressed or low mood, for more than 2 weeks and a loss of interest in activities thus affecting the mood and ability to function in daily life. To know more about Major Depressive Disorder (MDD), visit - https://www.globalinsightservices.com/reports/major-depressive-disorder-mdd-drug-pipeline-landscape-2022/ The most common causes of Major Depressive Disorder include genetics, trauma, isolation,
Chronic Depressive Personality Disorder Treatment Market Forecast over 2017 – …
Chronic Depressive Personality Disorder Treatment Market: Key Players Some of the market participants in the global chronic depressive personality disorder treatment market are Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline plc, Merck Sharp & Dohme Corp., Pfizer, Inc., Allergan and Novartis AG. These companies are investing on research and development to develop more effective treatment option for chronic depressive personality disorder. Companies are also focusing on collaboration strategies for chronic depressive